Status:

COMPLETED

Improving Insulin Resistance and Energy Metabolism Through Sleep Extension in Adolescents

Lead Sponsor:

University of Colorado, Denver

Conditions:

Sleep

Diabetes Mellitus, Type 2

Eligibility:

All Genders

13-19 years

Phase:

NA

Brief Summary

The investigators propose to deliver a 4-week sleep extension intervention to adolescents to evaluate feasibility of the protocol and obtain preliminary data on intra-individual changes in metabolic p...

Detailed Description

The specific aims of this feasibility study are to 1) examine the feasibility of recruitment and retention of adolescents with overweight/obesity, pre-diabetes, and inadequate sleep into a sleep exten...

Eligibility Criteria

Inclusion

  • High school students between the age of 13-19 years
  • BMI \>85th percentile for age and sex
  • Prediabetes defined as a HbA1c 5.7-6.4%
  • Tanner Stage 4-5 (based on breast development for girls and testicular size for boys)

Exclusion

  • Any medications that affect insulin resistance or sleep (e.g., metformin, stimulants, atypical antipsychotics, current use of oral steroids)
  • Regular use of melatonin or other sleep aids
  • A prior diagnosis of a sleep disorder (e.g. insomnia, delayed sleep phase syndrome, obstructive sleep apnea) or abnormal scores on sleep disorders screening measures
  • Type 2 diabetes (HbA1c ≥ 6.5%)
  • IQ\<70 or severe mental illness that may impact sleep or ability to consent/assent (e.g., schizophrenia, psychotic episodes), verified through chart review
  • Teens not enrolled in a traditional high school academic program (e.g., home school students)
  • Schedules that would preclude participants from adhering to the sleep extension protocol (e.g. night shift employment)
  • Travel across more than two time zones in the 2 weeks prior to the study

Key Trial Info

Start Date :

March 21 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 31 2023

Estimated Enrollment :

10 Patients enrolled

Trial Details

Trial ID

NCT03814512

Start Date

March 21 2019

End Date

December 31 2023

Last Update

October 1 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Children's Hospital Colorado

Lafayette, Colorado, United States, 80026